scispace - formally typeset
A

Ahmed M. El Kerdawy

Researcher at Cairo University

Publications -  59
Citations -  1002

Ahmed M. El Kerdawy is an academic researcher from Cairo University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 14, co-authored 43 publications receiving 565 citations. Previous affiliations of Ahmed M. El Kerdawy include University of Erlangen-Nuremberg.

Papers
More filters
Journal ArticleDOI

Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives

TL;DR: Increasing the hydrophobic interaction was accomplished by extending the anilinophthalazine scaffold with a substituted phenyl moiety through an uriedo linker which should give this extension the flexibility required to accommodate itself deeply into theHydrophobic back pocket of the VEGFR-2 active site.
Journal ArticleDOI

Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.

TL;DR: Inhibition of angiogenesis through inhibition of vascular endothelial growth factor receptor 2 (VEGFR-2) has been applied in cancer therapy because of its important role in promoting cancer growth and metastasis and structure-activity relationship was inferred for future optimization.
Journal ArticleDOI

Directional Noncovalent Interactions: Repulsion and Dispersion.

TL;DR: The interaction energies between an argon atom and the dihalogens Br2, BrCl, and BrF have been investigated using frozen core CCSD(T)(fc)/aug-cc-pVQZ calculations as reference values for other levels of theory, and the newly developed EXXRPA+@dRPA functional represents a systematic improvement on EXxRPA-@EXX.
Journal ArticleDOI

New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies

TL;DR: Motivated by the potential anticancer activity of both coumarin and 2-aminothiazole nuclei, a new set of thiazol-2-yl hydrazono-chromen-1-one analogs were efficiently synthesized aiming to obtain novel hybrids with potential cytotoxic activity.
Journal ArticleDOI

Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors.

TL;DR: A hybridization strategy was adopted to combine the binding features of the non-selective COX inhibitor "sulindac" and the selective COX-2 inhibitor "celecoxib" with that of licofelone and a celecoxib pyridone analogue to design new series of pyrazole sulfonamide derivatives which, by design, should possess dual COx-2/5-LOX inhibitory activity.